Comparative trends in the incidence of hospitalized myocardial infarction and coronary heart disease in adults with and without diabetes mellitus in Western Australia from 1998 to 2010

Circulation: Cardiovascular Quality and Outcomes

Volumn 7, Issue 5, 2014, Pages 708-717

  Nedkoff, Lee ^a   Knuiman, Matthew ^a   Hung, Joseph ^a,b   Briffa, Tom G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Coronary disease; Diabetes mellitus; Incidence; Myocardial infarction; Trends

Indexed keywords

ADULT; ADULT DISEASE; AGED; AUSTRALIA; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; TREND STUDY; CORONARY DISEASE; DIABETES COMPLICATIONS; HOSPITALIZATION; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK;

EID: 84925684929     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.114.000952     Document Type: Review

References (44)

1. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215-2222
2. Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008;117:1945-1954
3. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398
4. Sanfilippo FM, Hobbs MS, Knuiman MW, Hung J. Impact of new biomarkers of myocardial damage on trends in myocardial infarction hospital admission rates from population-based administrative data. Am J Epidemiol. 2008;168:225-233
5. Nedkoff L, Briffa TG, Knuiman M, Hung J, Norman PE, Hankey GJ, Thompson PL, Geelhoed E, Sanfilippo FM, Hickling S, Bremner A, Hobbs M. Temporal trends in the incidence and recurrence of hospitalised atherothrombotic disease in an Australian population, 2000-07: data linkage study. Heart. 2012;98:1449-1456
6. Icks A, Dickhaus T, Hörmann A, Heier M, Giani G, Kuch B, Meisinger C. Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) registry. Diabetologia. 2009;52:1836-1841
7. Rautio A, Lundberg V, Messner T, Nasic S, Stegmayr B, Eliasson M. Favourable trends in the incidence and outcome of myocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarction registry in northern Sweden in 1989-2000. J Intern Med. 2005;258:369-377
8. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB Sr, Wilson PW, Savage PJ. Trends in cardiovascular complications of diabetes. JAMA. 2004;292:2495-2499
9. Fox CS, Coady S, Sorlie PD, D'Agostino RB Sr, Pencina MJ, Vasan RS, Meigs JB, Levy D, Savage PJ. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115:1544-1550
10. Epidemiology Branch. Western Australian Health and Wellbeing Surveillance System. http://www.health.wa.gov.au/publications/pop-surveys. cfm. 2013. Accessed June 20, 2013
11. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2-7 million participants. Lancet. 2011;378:31-40
12. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253-259
13. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009;53:298-304
14. Holden SH, Barnett AH, Peters JR, Jenkins-Jones S, Poole CD, Morgan CL, Currie CJ. The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. 2013;15:844-852
15. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB Sr, Savage PJ, Levy D, Fox CS. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation. 2009;119:1728-1735
16. Australian Bureau of Statistics (ABS). Australian Demographic Statistics Mar 2010. http://www.abs.gov.au/AUSSTATS/abs@nsf/ DetailsPage/3101.0Jun%202010?OpenDocument. Accessed February 21, 2013
17. Clark A, Preen DB, Ng JQ, Semmens JB, Holman CD. Is Western Australia representative of other Australian States and Territories in terms of key socio-demographic and health economic indicators? Aust Health Rev. 2010;34:210-215
18. Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23:453-459
19. Manuel DG, Lim JJ, Tanuseputro P, Stukel TA. How many people have had a myocardial infarction? Prevalence estimated using historical hospital data. BMC Public Health. 2007;7:174
20. Sanfilippo FM, Hobbs MS, Knuiman MW, Ridout SC, Bradshaw PJ, Finn JC, Rankin JM, Sprivulis PC, Hung J. Can we monitor heart attack in the troponin era? Evidence from a population-based cohort study. BMC Cardiovasc Disord. 2011;11:35
21. Nedkoff L, Knuiman M, Hung J, Sanfilippo FM, Katzenellenbogen JM, Briffa TG. Concordance between administrative health data and medical records for diabetes status in coronary heart disease patients: a retrospective linked data study. BMC Med Res Methodol. 2013;13:121
22. Australian Institute of Health and Welfare (AIHW): Tong B, Stevenson C. Comorbidity of Cardiovascular Disease, Diabetes and Chronic Kidney Disease in Australia. Canberra: AIHW; 2007
23. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291-1297
24. Ford ES. Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: findings from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes Care. 2011;34:1337-1343
25. Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009; 52:2288-2298
26. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589
27. Australian Institute of Health and Welfare (AIHW). Diabetes Australian Facts 2008. Canberra: AIHW; 2008
28. Davis TM, Davis Cyllene Uwa Edu Au WA, Bruce DG. Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study. Med J Aust. 2006;184:325-328
29. Best JD, Drury PL, Davis TM, Taskinen MR, Kesäniemi YA, Scott R, Pardy C, Voysey M, Keech AC; Fenofibrate Intervention and Event Lowering in Diabetes Study Investigators. Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort. Diabetes Care. 2012;35:1165-1170
30. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393
31. The Practical Implementation Taskforce for the Prevention of Cardiovascular Disease. Prevention of cardiovascular disease: an evidence-based clinical aid 2004. Med J Aust. 2004; 181:F1-F16
32. National Prescribing Service. Revised PBS Criteria for Lipid-Modifying Drugs; 2007. http://www.pbs.gov.au/info/publication/schedule/archive. Accessed July 5, 2014
33. Page MM, Sanfilippo FM, Geelhoed EA, Briffa TG, Hobbs MS. Earlier translation of evidence into public subsidy may prevent morbidity and mortality: an example using statins in diabetics with normal cholesterol levels. Aust N Z J Public Health. 2012;36:435-440
34. National Association of Diabetes Centres. Australian National Diabetes Information Audit and Benchmarking Final Report 2011. http://www. health.gov.au/internet/publications/publishing.nsf/Content/pq-diabetespubs-andiab11-toc. Accessed April 8, 2014
35. APCC. Australian Primary Care Collaboratives Program 2011. http://www. Apcc.org.au/about-the-APCC/program-results/. Accessed April 2, 2014
36. Roger VL, Weston SA, Gerber Y, Killian JM, Dunlay SM, Jaffe AS, Bell MR, Kors J, Yawn BP, Jacobsen SJ. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation. 2010;121:863-869
37. Salomaa V, Koukkunen H, Ketonen M, Immonen-Räihä P, Kärjä-Koskenkari P, Mustonen J, Lehto S, Torppa J, Lehtonen A, Tuomilehto J, Kesäniemi YA, Pyörälä K; for the FINAMI Study Group. A new definition for myocardial infarction: what difference does it make? Eur Heart J. 2005;26:1719-1725
38. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, Wians F, Sabatine MS, Morrow DA, de Lemos JA. Prevalence and determinants of troponin T elevation in the general population. Circulation. 2006;113:1958-1965
39. Brameld KJ, Ward A, Gavin AL, Holman CD. Health outcomes in people with type 2 diabetes. A record linkage study. Aust Fam Physician. 2002;31:775-778, 782
40. Hung J, Brieger DB, Amerena JV, Coverdale SG, Rankin JM, Astley CM, Soman A, Chew DP. Treatment disparities and effect on late mortality in patients with diabetes presenting with acute myocardial infarction: observations from the ACACIA registry. Med J Aust. 2009;191:539-543
41. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27:1879-1884
42. Gore MO, Patel MJ, Kosiborod M, Parsons LS, Khera A, de Lemos JA, Rogers WJ, Peterson ED, Canto JC, McGuire DK; National Registry of Myocardial Infarction Investigators. Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012;5:791-797
43. Nedkoff LJ, Briffa TG, Preen DB, Sanfilippo FM, Hung J, Ridout SC, Knuiman M, Hobbs M. Age-and sex-specific trends in the incidence of hospitalized acute coronary syndromes in Western Australia. Circ Cardiovasc Qual Outcomes. 2011;4:557-564
44. Sulo G, Igland J, Nygård O, Vollset SE, Ebbing M, Tell GS. Favourable trends in incidence of AMI in Norway during 2001-2009 do not include younger adults: a CVDNOR project [Epub ahead of print, July 11, 2013]. Eur J Prev Cardiol. 2013. doi:10.1177/2047487313495993.